Skip to main content
. 2019 Jun 26;11(7):1441. doi: 10.3390/nu11071441

Table 4.

Metabolites excreted in urine (from 0 to 24 h) by healthy volunteers after consumption of the conventional soluble cocoa product (CC) containing 19.80 mg of flavanols.

Metabolite Basal (µmol) 0–4 h (µmol) 4–8 h (µmol) 8–12 h (µmol) 12–24 h (µmol) Total (µmol)
Intestinal Absorption Epicatechin-3′-glucuronide N.D. 0.355 ± 0.071 0.267 ± 0.059 <L.Q. <L.Q. 0.622 ± 0.130 *
Epicatechin-3′-methoxy-glucuronide N.D. <L.Q. <L.Q. N.D. N.D. <L.Q. *
Epicatechin-3′-sulfate N.D. 1.323 ± 0.236 1.018 ± 0.178 0.076 ± 0.025 <L.Q. 2.417 ± 0.439 *
Epicatechin-methoxy-sulfate (isomer 1) N.D. 2.717 ± 0.457 1.300 ± 0.197 0.154 ± 0.031 0.257 ± 0.114 4.428 ± 0.800 *
Epicatechin-methoxy-sulfate (isomer 2) N.D. 0.181 ± 0.032 0.247 ± 0.030 <L.Q. <L.Q. 0.428 ± 0.062 *
Epicatechin-methoxy-sulfate (isomer 3) N.D. 0.473 ± 0.089 0.285 ± 0.036 <L.Q. N.D. 0.758 ± 0.125 *
Total—intestinal absorption N.D. 5.049 ± 0.885 3.117 ± 0.500 0.230 ± 0.056 0.257 ± 0.114 8.653 ± 1.556 *
Colonic Absorption DHPVL <L.Q. <L.Q. 0.146 ± 0.032 <L.Q. <L.Q. 0.146 ± 0.032 *
HPVL N.D. N.D. <L.Q. <L.Q. <L.Q. <L.Q. *
HDHPVA N.D. N.D. <L.Q. <L.Q. <L.Q. <L.Q.
HPVL-4′-glucuronide <L.Q. <L.Q. 0.111 ± 0.049 <L.Q. <L.Q. 0.111 ± 0.049 *
HPVL-3′-glucuronide <L.Q. <L.Q. 0.497 ± 0.204 0.103 ± 0.028 <L.Q. 0.600 ± 0.232 *
HPVL-sulfate 0.143 ± 0.064 0.456 ± 0.193 5.638 ± 1.922 1.945 ± 0.647 1.744 ± 0.374 9.926 ± 3.200 *
PVL-methoxy-glucuronide <L.Q. <L.Q. 0.111 ± 0.039 <L.Q. <L.Q. 0.111 ± 0.039 *
PVL-methoxy-sulfate <L.Q. N.D. 0.085 ± 0.031 <L.Q. <L.Q. 0.085 ± 0.031 *
PVL-3′glucuronide N.D. <L.Q. 0.233 ± 0.155 0.126 ± 0.078 0.079 ± 0.022 0.438 ± 0.255
PVL-3′-sulfate <L.Q. <L.Q. 0.860 ± 0.385 0.456 ± 0.284 0.375 ± 0.133 1.691 ± 0.802 *
HHPVA-glucuronide N.D. N.D. N.D. N.D. N.D. N.D. *
HHPVA-sulfate 0.089 ± 0.055 0.076 ± 0.055 1.112 ± 0.397 0.565 ± 0.171 0.503 ± 0.152 2.345 ± 0.830 *
Total—colonic absorption 0.232 ± 0.119 0.532 ± 0.248 8.793 ± 3.214 3.195 ± 1.208 2.701 ± 0.681 15.453 ± 5.470 *
Other microbial metabolites 3,4-Dihydroxyphenylpropionic acid 0.117 ± 0.024 0.217 ± 0.051 0.243 ± 0.039 0.074 ± 0.017 0.215 ± 0.016 0.866 ± 0.148
3-Methoxy-4-hydroxyphenylpropionic acid 0.104 ± 0.027 0.144 ± 0.044 <L.Q. <L.Q. <L.Q. 0.248 ± 0.071
Hydroxyphenylpropionic acid 0.118 ± 0.023 0.226 ± 0.046 0.259 ± 0.043 0.077 ± 0.018 0.203 ± 0.025 0.883 ± 0.154
3,4-Dihydroxyphenylacetic acid 0.094 ± 0.032 0.648 ± 0.505 0.556 ± 0.379 0.094 ± 0.033 0.133 ± 0.020 1.525 ± 0.974
3-Methoxy-4-hydroxyphenylacetic acid 0.103 ± 0.014 0.099 ± 0.054 0.093 ± 0.028 <L.Q. 0.103 ± 0.022 0.398 ± 0.118
Hydroxyphenylacetic acid 0.369 ± 0.077 0.408 ± 0.084 0.605 ± 0.092 0.225 ± 0.052 0.600 ± 0.100 2.208 ± 0.328
Ferulic acid <L.Q. <L.Q. 0.094 ± 0.009 0.099 ± 0.059 N.D. 0.193 ± 0.068
Isoferulic acid 0.170 ± 0.137 0.086 ± 0.028 0.096 ± 0.040 0.088 ± 0.069 0.082 ± 0.016 0.522 ± 0.290
Protocatechuic acid 0.161 ± 0.071 0.227 ± 0.142 0.373 ± 0.237 0.094 ± 0.047 0.104 ± 0.044 0.959 ± 0.217 *
Hydroxyhippuric acid 0.821 ± 0.251 0.864 ± 0.154 1.171 ± 0.387 0.242 ± 0.067 0.995 ± 0.316 4.093 ± 1.175
Hydroxyhippuric acid 0.075 ± 0.031 0.085 ± 0.043 0.082 ± 0.055 0.075 ± 0.031 0.077 ± 0.046 0.394 ± 0.206
Hidroxybenzoic acid 0.188 ± 0.041 0.145 ± 0.027 0.200 ± 0.051 0.070 ± 0.018 0.195 ± 0.025 0.798 ± 0.162
Total other microbial metabolites 2.320 ± 0.728 3.149 ± 1.178 3.772 ± 1.360 1.138 ± 0.411 2.707 ± 0.630 13.086 ± 3.911
INTESTINAL + COLONIC METABOLITES 0.232 ± 0.119 5.581 ± 1.133 11.910 ± 3.714 3.425 ± 1.264 2.958 ± 0.795 24.106 ± 7.026

HDHPVA: 4-hydroxy-5-(3′,4′-dihydroxyphenyl)valeric acid; DHPVL: 5-(3′,4′-dihydroxyphenyl)-γ-valerolactone; HPVL: 5-(3′-hydroxyphenyl)-γ-valerolactone; PVL: 5-phenyl-γ-valerolactone. * Significant differences respect to CC-PP intervention was observed based on non-parametric Wilcoxon test at p < 0.05. Values represent mean ± standard deviation (n = 13). N.D.: not detected; <L.Q. lower than quantification limit.